Joel’s current responsibilities include enterprise and business strategy across the One Clarivate four industry segments, competitive intelligence and M&A. He brings extensive experience built over 32 years working with customers globally across industries, with 13 of those years focused on life sciences and healthcare. Joel has a passion for the use of digital technologies by medical professionals and patients and serves on the board of two innovative digital health companies, FollowApp Care and Lifelight.
Latest news
New Clarivate Report Reveals Mainland China as Emerging Global Biopharma Innovation Leader
Out-Licensing Deals Reach $50 Billion as Chinese Biopharma Innovators Drive Breakthrough Science LONDON, U.K. December 8, 2025 Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, in partnership…
Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance
Powered by agentic AI, new features help regulatory teams improve accuracy and enable faster, more confident decisions across the product lifecycle London, U.K. — December 4, 2025 — Clarivate Plc…
Clarivate and the Chinese Academy of Sciences Release the 2025 Research Fronts Report
Annual report identifies 110 hot and 18 emerging Research Fronts London, U.K. December 3, 2025. Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, and the Chinese Academy…